Copyright Reports & Markets. All rights reserved.

Global Hetrombopag Ethanolamine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hetrombopag Ethanolamine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 2.5 mg/tablet
    • 1.3.3 5 mg/tablet
  • 1.4 Market Analysis by Sales Channels
    • 1.4.1 Overview: Global Hetrombopag Ethanolamine Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Retail
    • 1.4.4 Online
  • 1.5 Market Analysis by Dosage Form
    • 1.5.1 Overview: Global Hetrombopag Ethanolamine Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.5.2 Tablets
    • 1.5.3 Powder
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Hetrombopag Ethanolamine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Primary Immune Thrombocytopenia (ITP)
    • 1.6.3 Cancer Therapy–related Thrombocytopenia
    • 1.6.4 Aplastic Anemia (AA)
    • 1.6.5 Others
  • 1.7 Global Hetrombopag Ethanolamine Market Size & Forecast
    • 1.7.1 Global Hetrombopag Ethanolamine Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Hetrombopag Ethanolamine Sales Quantity (2021-2032)
    • 1.7.3 Global Hetrombopag Ethanolamine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Jiangsu Hengrui Pharmaceuticals
    • 2.1.1 Jiangsu Hengrui Pharmaceuticals Details
    • 2.1.2 Jiangsu Hengrui Pharmaceuticals Major Business
    • 2.1.3 Jiangsu Hengrui Pharmaceuticals Hetrombopag Ethanolamine Product and Services
    • 2.1.4 Jiangsu Hengrui Pharmaceuticals Hetrombopag Ethanolamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
  • 2.2 Luzsana Biotechnology
    • 2.2.1 Luzsana Biotechnology Details
    • 2.2.2 Luzsana Biotechnology Major Business
    • 2.2.3 Luzsana Biotechnology Hetrombopag Ethanolamine Product and Services
    • 2.2.4 Luzsana Biotechnology Hetrombopag Ethanolamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Luzsana Biotechnology Recent Developments/Updates

3 Competitive Environment: Hetrombopag Ethanolamine by Manufacturer

  • 3.1 Global Hetrombopag Ethanolamine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hetrombopag Ethanolamine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hetrombopag Ethanolamine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hetrombopag Ethanolamine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hetrombopag Ethanolamine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hetrombopag Ethanolamine Manufacturer Market Share in 2025
  • 3.5 Hetrombopag Ethanolamine Market: Overall Company Footprint Analysis
    • 3.5.1 Hetrombopag Ethanolamine Market: Region Footprint
    • 3.5.2 Hetrombopag Ethanolamine Market: Company Product Type Footprint
    • 3.5.3 Hetrombopag Ethanolamine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hetrombopag Ethanolamine Market Size by Region
    • 4.1.1 Global Hetrombopag Ethanolamine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hetrombopag Ethanolamine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hetrombopag Ethanolamine Average Price by Region (2021-2032)
  • 4.2 North America Hetrombopag Ethanolamine Consumption Value (2021-2032)
  • 4.3 Europe Hetrombopag Ethanolamine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hetrombopag Ethanolamine Consumption Value (2021-2032)
  • 4.5 South America Hetrombopag Ethanolamine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hetrombopag Ethanolamine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Hetrombopag Ethanolamine Sales Quantity by Type (2021-2032)
  • 5.2 Global Hetrombopag Ethanolamine Consumption Value by Type (2021-2032)
  • 5.3 Global Hetrombopag Ethanolamine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hetrombopag Ethanolamine Sales Quantity by Application (2021-2032)
  • 6.2 Global Hetrombopag Ethanolamine Consumption Value by Application (2021-2032)
  • 6.3 Global Hetrombopag Ethanolamine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hetrombopag Ethanolamine Sales Quantity by Type (2021-2032)
  • 7.2 North America Hetrombopag Ethanolamine Sales Quantity by Application (2021-2032)
  • 7.3 North America Hetrombopag Ethanolamine Market Size by Country
    • 7.3.1 North America Hetrombopag Ethanolamine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hetrombopag Ethanolamine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hetrombopag Ethanolamine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Hetrombopag Ethanolamine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hetrombopag Ethanolamine Market Size by Country
    • 8.3.1 Europe Hetrombopag Ethanolamine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hetrombopag Ethanolamine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hetrombopag Ethanolamine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Hetrombopag Ethanolamine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hetrombopag Ethanolamine Market Size by Region
    • 9.3.1 Asia-Pacific Hetrombopag Ethanolamine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hetrombopag Ethanolamine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hetrombopag Ethanolamine Sales Quantity by Type (2021-2032)
  • 10.2 South America Hetrombopag Ethanolamine Sales Quantity by Application (2021-2032)
  • 10.3 South America Hetrombopag Ethanolamine Market Size by Country
    • 10.3.1 South America Hetrombopag Ethanolamine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hetrombopag Ethanolamine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hetrombopag Ethanolamine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Hetrombopag Ethanolamine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hetrombopag Ethanolamine Market Size by Country
    • 11.3.1 Middle East & Africa Hetrombopag Ethanolamine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hetrombopag Ethanolamine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hetrombopag Ethanolamine Market Drivers
  • 12.2 Hetrombopag Ethanolamine Market Restraints
  • 12.3 Hetrombopag Ethanolamine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hetrombopag Ethanolamine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hetrombopag Ethanolamine
  • 13.3 Hetrombopag Ethanolamine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hetrombopag Ethanolamine Typical Distributors
  • 14.3 Hetrombopag Ethanolamine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hetrombopag Ethanolamine market size was valued at US$ 250 million in 2025 and is forecast to a readjusted size of US$ 625 million by 2032 with a CAGR of 10.6% during review period.
    In 2025, global Herombopag Ethanolamine production reached approximately 165,000 units.Hetrombopag Ethanolamine is an orally administered small-molecule thrombopoietin receptor agonist (TPO-RA), primarily used for the treatment of thrombocytopenia-related disorders. It is the ethanolamine salt form of hetrombopag and works by selectively activating the thrombopoietin receptor (c-Mpl), thereby promoting the proliferation and differentiation of megakaryocytes and increasing platelet production.Clinically, the drug is mainly used for the treatment of conditions such as primary immune thrombocytopenia (ITP), effectively improving platelet counts and reducing the risk of bleeding. Compared with traditional therapies, hetrombopag ethanolamine offers advantages including convenient oral administration, stable efficacy, and a favorable safety profile.As one of the innovative drugs independently developed in China, it demonstrates promising application prospects in the treatment of hematological diseases.
    Hetrombopag Ethanolamine, as an orally administered thrombopoietin receptor agonist (TPO-RA) independently developed in China, is primarily positioned in the treatment market for thrombocytopenia, particularly addressing clear clinical needs in indications such as primary immune thrombocytopenia (ITP). With the acceleration of population aging, the rising incidence of thrombocytopenia associated with cancer therapies, and increasing attention to bleeding risk management, the global thrombocytopenia treatment market continues to expand, providing stable growth opportunities for this drug. From a competitive perspective, existing therapies such as eltrombopag and romiplostim have already captured a certain market share; however, their relatively high cost or limitations in administration routes (e.g., injection) create opportunities for next-generation oral agents with improved safety profiles.
    In the Chinese market, government support for innovative drugs, the continuous improvement of reimbursement negotiation mechanisms, and enhanced patient accessibility are expected to facilitate the market penetration of hetrombopag ethanolamine. Meanwhile, with the gradual updates of clinical guidelines and increasing physician awareness of TPO-RA therapies, its role in standardized treatment is likely to be further strengthened. From a global perspective, demand for treatments in hematological diseases continues to grow; however, expansion into international markets will still require additional clinical evidence and progress in regulatory approvals.
    This report is a detailed and comprehensive analysis for global Hetrombopag Ethanolamine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hetrombopag Ethanolamine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Hetrombopag Ethanolamine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Hetrombopag Ethanolamine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Hetrombopag Ethanolamine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hetrombopag Ethanolamine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hetrombopag Ethanolamine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hengrui Pharmaceuticals, Luzsana Biotechnology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hetrombopag Ethanolamine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    2.5 mg/tablet
    5 mg/tablet
    Market segment by Sales Channels
    Hospital
    Retail
    Online
    Market segment by Dosage Form
    Tablets
    Powder
    Market segment by Application
    Primary Immune Thrombocytopenia (ITP)
    Cancer Therapy–related Thrombocytopenia
    Aplastic Anemia (AA)
    Others
    Major players covered
    Jiangsu Hengrui Pharmaceuticals
    Luzsana Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hetrombopag Ethanolamine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hetrombopag Ethanolamine, with price, sales quantity, revenue, and global market share of Hetrombopag Ethanolamine from 2021 to 2026.
    Chapter 3, the Hetrombopag Ethanolamine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hetrombopag Ethanolamine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hetrombopag Ethanolamine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hetrombopag Ethanolamine.
    Chapter 14 and 15, to describe Hetrombopag Ethanolamine sales channel, distributors, customers, research findings and conclusion.

    Buy now